Sherlock Biosciences Launches with $35M, Aiming to Improve Diagnostic Testing

Sherlock Biosciences Launches with $35M, Aiming to Improve Diagnostic Testing »

22 Mar, 2019
CompaniesNews
  Cambridge-based engineering biology company Sherlock Biosciences this week announced its launch with $35 million in financing — and its eyes are on CRISPR gene-editing tech. Sherlock Biosciences aims to make diagnostic testing better, faster and more affordable. The company uses engineering biology tools, including CRISPR, to create a new generation of molecular diagnostics that rapidly…

Send this to a friend